Tracking SARS-COV-2 Variants Using Nanopore Sequencing in Ukraine in Summer 2021.


Journal

Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
30 Nov 2021
Historique:
entrez: 7 12 2021
pubmed: 8 12 2021
medline: 8 12 2021
Statut: epublish

Résumé

Since spring 2020, Ukraine has experienced at least two COVID-19 waves and has just entered a third wave in autumn 2021. The use of real-time genomic epidemiology has enabled the tracking of SARS-CoV-2 circulation patterns worldwide, thus informing evidence-based public health decision making, including implementation of travel restrictions and vaccine rollout strategies. However, insufficient capacity for local genetic sequencing in Ukraine and other Lower and Middle-Income countries limit opportunities for similar analyses. Herein, we report local sequencing of 24 SARS-CoV-2 genomes from patient samples collected in Kyiv in July 2021 using Oxford Nanopore MinION technology. Together with other published Ukrainian SARS-COV-2 genomes sequenced mostly abroad, our data suggest that the second wave of the epidemic in Ukraine (February-April 2021) was dominated by the Alpha variant of concern (VOC), while the beginning of the third wave has been dominated by the Delta VOC. Furthermore, our phylogeographic analysis revealed that the Delta variant was introduced into Ukraine in summer 2021 from multiple locations worldwide, with most introductions coming from Central and Eastern European countries. This study highlights the need to urgently integrate affordable and easily-scaled pathogen sequencing technologies in locations with less developed genomic infrastructure, in order to support local public health decision making.

Identifiants

pubmed: 34873595
doi: 10.21203/rs.3.rs-1044446/v1
pmc: PMC8647652
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : P20 GM103395
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI135992
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Emerg Infect Dis. 2020 Mar;26(3):481-490
pubmed: 32091369
Water Res. 2021 Jun 1;197:117104
pubmed: 33857895
Science. 2019 Feb 15;363(6428):677-678
pubmed: 30765543
BMJ. 2021 Apr 29;373:n1116
pubmed: 33926905
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
Sci Rep. 2020 Nov 12;10(1):19662
pubmed: 33184338
Infect Genet Evol. 2021 Nov;95:105087
pubmed: 34592415
Nature. 2021 May;593(7857):136-141
pubmed: 33706364
Pathogens. 2019 Jun 10;8(2):
pubmed: 31185670
Int J Drug Policy. 2019 May;67:91-101
pubmed: 30503695
Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Virology. 2021 Sep;561:107-116
pubmed: 34217923
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056
pubmed: 29339468
Vaccine. 2017 Aug 24;35(36):4769-4776
pubmed: 28528761
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Microbiol Resour Announc. 2019 Oct 17;8(42):
pubmed: 31624164
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
J Diabetes Sci Technol. 2020 Jul;14(4):754-755
pubmed: 32468843

Auteurs

Anna Yakovleva (A)

University of Oxford.

Ganna Kovalenko (G)

University of Cambridge.

Matthew Redlinger (M)

University of Alaska Anchorage.

Mariia G Liulchuk (MG)

State Institution "L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of National Academy of Medical Sciences of Ukraine".

Eric Bortz (E)

University of Alaska Anchorage.

Viktoria I Zadorozhna (VI)

State Institution "L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of National Academy of Medical Sciences of Ukraine".

Alla M Scherbinska (AM)

State Institution "L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases of National Academy of Medical Sciences of Ukraine".

Joel O Wertheim (JO)

University of California San Diego.

Ian Goodfellow (I)

University of Cambridge.

Luke Meredith (L)

University of Cambridge.

Tetyana I Vasylyeva (TI)

University of California San Diego.

Classifications MeSH